The supply chain that nobody questioned For decades, the global botanical ingredients industry operated on a straightforward model: source raw plant material from tropical and subtropical regions where labour is inexpensive and biodiversity is abundant, process it through a chain of intermediaries, and deliver it to European manufacturers for formulation. The primary selection criteria were price and availability. The system worked well enough when nobody looked too closely a

B Corp is everywhere. But what does it mean for a biotech company producing high-tech botanicals?